ATNM vs FDX · rev $35.0M vs P/E 18, rev $94.72B
Actinium Pharmaceuticals Inc (ATNM) versus FedEx Corporation (FDX) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported FDX revenue for 2026-05-31 was $94.72B. Net income was $4.43B. Revenue was up 7.7% from 2025-05-31 to 2026-05-31. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
ATNM currently screens at market cap $33.9M. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
Not investment advice. Open the ATNM and FDX stock pages for the full models.
Not investment advice.